Scrip Podcasts

Audio roundup of selected biopharma industry content from Scrip over the business week ended Aug. 21, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools.

This time—melanoma win for Moderna's mRNA candidate; lung cancer victory for Enhertu; measuring industry R&D productivity; Enveda's post-GLP-1 contender; and the factors behind China's rise.

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-ATTKRKGOMNAV3J6PRL2PAKBJKU/

Link to Pipeline to Patient Productivity Index report: https://www.norstella.com/p3i/

This and all our other podcasts are available on the new Scrip channel on Apple Podcasts, and Spotify Podcasts and on TuneIn.

Contact us on [email protected].

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年8月14日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。

本期要闻: 全球特发性肺纤维化（IPF）研发管线概览；武田制药的嗜睡症药物获美国批准；Arrowhead公司探讨严重高甘油三酯血症治疗方案的差异化；SMID公司第二季度进展；以及Attruby在伴有心肌病变的转甲状腺素蛋白介导的淀粉样变性中的定位。

Story link: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-X73TT3G6OVE7VPYRLSKYQRY5PY/

向听众们简要更新一下：Scrip现在已在Spotify和Apple Podcasts上开设了专属播客频道。

Audio roundup of selected biopharma industry content from Scrip over the business week ended Aug. 14, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools.

This time—a look at the global IPF pipeline; US approval for Takeda's narcolepsy drug; Arrowhead talks differentiation in severe hypertriglyceridemia; SMID Q2 developments; and Attruby positioning in transthyretin-mediated amyloidosis with cardiomyopathy.

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-X73TT3G6OVE7VPYRLSKYQRY5PY/

This and all our other podcasts are available on the new Scrip channel on Apple Podcasts, and Spotify Podcasts and on TuneIn.

Contact us on [email protected].

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年8月7日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。

本期要闻: 诺和诺德考虑进行补充性收购；拜耳抨击德国定价政策；尽管Foundayo表现不佳，礼来股价仍大幅上涨；欧洲生物技术企业力求实现跨越式发展；以及对阿斯利康与百时美施贵宝在亚太地区潜在合并的展望。

Story link: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-AGQ4WMY4Y5BBFP7F67BNWXIPM4/

向听众们简要更新一下：Scrip现在已在Spotify和Apple Podcasts上开设了专属播客频道。

Audio roundup of selected biopharma industry content from Scrip over the business week ended Aug. 7, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools.

This time—Novo Nordisk weighs bolt-on deals; Bayer slams Germany pricing; Lilly soars despite Foundayo struggles; European biotech wants to leapfrog; and a look at the potential AstraZeneca/BMS combination in APAC.

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-AGQ4WMY4Y5BBFP7F67BNWXIPM4/

This and all our other podcasts are available on the new Scrip channel on Apple Podcasts, and Spotify Podcasts and on TuneIn.

China has become an increasingly important part of global clinical development, with sponsors considering the region earlier than ever before as part of their broader development strategies.

In this episode, Meredith Landry, Managing Editor of Citeline's Custom Content, speaks with Catherine Xu, Senior Operations Manager at Novotech, about the factors reshaping China's role in global clinical development. Drawing on her extensive experience supporting international clinical programmes, Catherine shares insights into the changing perceptions of China, the evolving regulatory landscape, and what sponsors should consider when planning global development strategies.

In this conversation, they explore:

• Why more sponsors are rethinking China's role in global clinical development

• The opportunities and misconceptions shaping today's development strategies

• What sponsors should consider when incorporating China into global programmes

• How China's role in global clinical development could evolve over the coming years

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年7月31日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。

本期要闻: 阿斯利康收紧人工智能支出；Argenx的产品管线聚焦产品开发；葛兰素史克在推进III期临床试验计划的同时削减成本；赛诺菲对产品管线进行重新评估；以及中国业务新公司2.0版。

Story link: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-AN2QWPVGAZGCND565XO3QDMBBM/

向听众们简要更新一下：Scrip现在已在Spotify和Apple Podcasts上开设了专属播客频道。

Audio roundup of selected biopharma industry content from Scrip over the business week ended July 31, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools.

This time—AstraZeneca reins in AI spending; Argenx’s pipeline in a product play; GSK cutting costs amid Phase III plans; Sanofi’s pipeline reckoning; and NewCo version 2 for Chinese assets.

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-AN2QWPVGAZGCND565XO3QDMBBM/

This and all our other podcasts are available on the new Scrip channel on Apple Podcasts, and Spotify Podcasts and on TuneIn.

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年7月24日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。

本期要闻: 诺和诺德在肥胖症治疗领域起诉礼来；特朗普针对仿制药采取新的关税措施；诺华CEO称赞日本、抨击德国的定价政策；制药行业会迎来“稀土时刻”吗？；以及欧洲生物技术行业正处于十字路口。

Story/video links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-2BIDCWDH5BAVLJ2QXPT6EL5U44/

向听众们简要更新一下：Scrip现在已在Spotify和Apple Podcasts上开设了专属播客频道。